CAMBREX CORP (CBM) Stock Price, Forecast & Analysis
USA - New York Stock Exchange - NYSE:CBM -
CBM Key Statistics, Chart & Performance
The current stock price of CBM is 59.99 null. In the past month the price increased by 0.38%. In the past year, price increased by 32.52%.
CBM Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to CBM. When comparing the yearly performance of all stocks, CBM is one of the better performing stocks in the market, outperforming 79.22% of all stocks.
CBM Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to CBM. CBM has an average financial health and profitability rating.
CBM Financial Highlights
Over the last trailing twelve months CBM reported a non-GAAP Earnings per Share(EPS) of 1.3900000000000001. The EPS decreased by -65.16% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.94% | ||
| ROA | 2.44% | ||
| ROE | 5.44% | ||
| Debt/Equity | 0.76 |
CBM Forecast & Estimates
CBM Ownership
About CBM
Company Profile
Cambrex Corporation is an innovative life sciences company with a refreshingly human approach. Driven by passion, their pharmaceutical products, expertise and technologies accelerate customers' small molecule therapeutics into markets across the world. The company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis and controlled substances. Cambrex has transformed from a fine chemical manufacturer to a business with a singular focus on small molecule therapeutics.
Company Info
CAMBREX CORP
ONE MEADOWLANDS PLZ
EAST RUTHERFORD NJ 07073
CEO: Steven M. Klosk
Phone: 201-804-3000
CAMBREX CORP / CBM FAQ
Can you describe the business of CAMBREX CORP?
Cambrex Corporation is an innovative life sciences company with a refreshingly human approach. Driven by passion, their pharmaceutical products, expertise and technologies accelerate customers' small molecule therapeutics into markets across the world. The company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis and controlled substances. Cambrex has transformed from a fine chemical manufacturer to a business with a singular focus on small molecule therapeutics.
What is the stock price of CAMBREX CORP today?
The current stock price of CBM is 59.99 null.
Does CBM stock pay dividends?
CBM does not pay a dividend.
What is the ChartMill rating of CAMBREX CORP stock?
CBM has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Where is CAMBREX CORP (CBM) stock traded?
CBM stock is listed on the New York Stock Exchange exchange.
What is CAMBREX CORP worth?
CAMBREX CORP (CBM) has a market capitalization of 2.02B null. This makes CBM a Mid Cap stock.